Is It Time We Stamp Out The Stigma Associated With Depression?
Source: Life Science Leader
By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
One of the presentations I attended during this year’s annual JPM Conference was that of Sage Therapeutics, a company we featured in our July 2018 issue (“Sage Therapeutics — Sitting On The Brink Of CNS Breakthroughs”). I briefly met Sage’s CEO, Jeff Jonas, M.D., after his presentation, to thank him in person for sharing his company’s story with our readers. I had enjoyed my interviews with Jonas, not only for his candor but also because of my interest in Sage’s therapeutic area of focus — depression.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more